The PI3K-AKT and Ras-ERK pathways regulate migration, invasion, and many other characteristics of cancer cells through multiple downstream effectors, establishing complex signaling networks that pose a huge challenge for the development of anticancer drugs [reviewed in Sever and Brugge (2015)]. The gene discussed is AKT1; the disease is cancer.